血小板数量非常高是否总是与基本血小板血有关? 一个孩子的不寻常的呈现
Elif Habibe Aktekin1, Nalan Yazici1, İlknur Kozanoğlu2
1Department of Pediatrics Division of Pediatric Hematology-Oncology, Baskent University, Adana, Turkey.
Laboratory medicine
|June 23, 2023
概括
这项研究报告了一例罕见的费城染色体和JAK2V617F突变在患有慢性髓性白血病 (CML) 的儿童中共存的罕见病例. 这一意想不到的发现在治疗儿科骨髓增殖性瘤方面带来了独特的挑战.
科学领域:
- 儿科血液学 儿科血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 骨髓增殖性瘤 (MPNs) 在儿童中不常见.
- MPNs被分类为费城染色体阳性或阴性.
- 慢性髓性白血病 (CML) 通常涉及费城染色体 (BCR-ABL),而其他MPN通常具有JAK2V617F突变.
研究的目的:
- 报告一例罕见的儿童CML患者同时存在BCR-ABL和JAK2V617F异常的罕见病例.
- 突出与儿童这种罕见的遗传组合相关的诊断和管理挑战.
主要方法:
- 一个儿科患者的病例报告,血小板数量很高.
- 基因分析以检测BCR-ABL重组和JAK2V617F突变.
- 对临床表现,实验室发现和治疗策略的审查.
主要成果:
- 这位患者的血小板数量非常高.
- 确定了BCR-ABL重组 (费城染色体阳性) 和JAK2V617F突变的同时存在.
- 这种双重遗传异常在儿科CML中非常罕见.
结论:
- 费城染色体和JAK2V617F突变在儿科CML中的共存是罕见的,并带来了重大的临床挑战.
- 需要进一步的研究,以了解这种罕见的儿童疾病的临床影响,最佳管理和预后.
相关概念视频
Structure and Function of Platelets
1.3K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.3K
Disorders of Hemostasis
1.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
567
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
567
Formation of the Platelet Plug
6.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K


